Suresh founded Saama Technologies in 1997 to help customers access previously unattainable insights of raw data across disparate sources via game-changing analytics solutions. Suresh served as Saama’s CEO for 25 years, leveraging AI to reshape businesses across different verticals, including Life Sciences, Insurance, CPG, and High- Tech.

Prior to being elevated to Chairman Emeritus of Saama’s Board in June, 2022, Suresh stewarded Saama’s partnership with Pfizer to develop the world’s first COVID- 19 vaccine in less than one year. In 2021 he architected a

bold new strategic growth investment for Saama with global investment firm Carlyle and a unique and unprecedented consortium of the corporate venture arms of major pharmaceutical companies.

As one of the world’s most inspiring data & analytics (D&A) innovators, Suresh sits on the Board of Directors of the Association of Clinical Research Organizations (ACRO), which is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results. Suresh was named PM360’s 2018 ELITE Entrepreneur and as one of PharmaVOICE’s 100 Most Inspirational Leaders, is a frequent contributor to industry publications, and is a sought-after featured speaker for industry conferences and panels.

Education

M.S. in Computer Engineering at the University of Southwest Louisiana

B.S. in Electronics Engineering at the University of Bangalore.